Loss of cytomegalovirus-specific immunological memory in a patient with thymoma

Clinical and Experimental Immunology

Volumn 129, Issue 2, 2002, Pages 297-301

  Huissoon, A P ^a,c   Davies, G ^b   Cox, R A ^a   Sloper, C M L ^a   Thomson, B J ^b   Robins, R A ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^c BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

Author keywords

Cytomegalovirus; Immunodeficiency; Retinitis; Thymoma

Indexed keywords

CD4 ANTIGEN;

AGED; ARTICLE; CASE REPORT; CELL FUNCTION; CONTROLLED STUDY; CONVALESCENCE; CROHN DISEASE; CYTOMEGALOVIRUS; DISEASE SEVERITY; HELPER CELL; HUMAN; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNOLOGICAL MEMORY; PRIORITY JOURNAL; RETINITIS; STIMULATION; T LYMPHOCYTE; THYMOMA;

AGED; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS RETINITIS; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MALE; OPPORTUNISTIC INFECTIONS; T-LYMPHOCYTES; THYMOMA; THYMUS NEOPLASMS;

EID: 0036379298     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2002.01923.x     Document Type: Article

References (13)

1. Whitcup SM. Cytomegalovirus retinitis in the era of highly active anti-retroviral therapy. JAMA 2000; 283:53-7.
2. Papanicolaou GA, Meyers BR, Fuchs WS, Guillory SL, Mendelson MH, Sheiner P, Emre S, Miller C. Infectious ocular complications in orthotopic liver transplant patients. Clin Infect Dis 1997; 24:1172-7.
3. Fishburne BC, Mitrani AA, Davis JL. Cytomegalovirus retinitis after cardiac transplantation. Am J Ophthalmol 1998; 125:104-6.
4. Okamoto T, Okada M, Mori A et al. Successful treatment of severe cytomegalovirus retinitis with foscarnet and intraocular injection of ganciclovir in a myelosuppressed unrelated bone marrow transplant patient. Bone Marrow Transplant 1997; 20:801-3.
5. Tarr PE, Sneller MC, Mechanic LJ, Economides A, Eger CE, Strober W, Cunningham-Rundles C, Lucey DR. Infections in patients with immunodeficiency and thymoma (Good Syndrome). Medicine 2001; 80:123-33.
6. Masci AM, Palmieri G, Perna F, Monatella L, Merkabaoui G, Sacerdoti G, Martignetti A, Racioppi L. Immunological findings in thymoma and thymoma-related syndromes. Ann Med 1999; 31S:uppl; 2:86-9.
7. Asanuma H, Sharp M, Maecker HT, Maino VC, Arvin AM. Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression. J Infect Dis 2000; 181:859-66.
8. Polic B, Hengel H, Krmpotic A, Trgovcich J, Pavic I, Luccaronin P, Jonjic S, Koszinowski UH. Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J Exp Med 1998; 188:1047-54.
9. Presti RM, Pollock JL, Dal Canto AJ, O'Guin AK, Virgin HW 4th. Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels. J Exp Med 1998; 188:577-88.
10. Biron CA, Bryon KS, Sullivan J. Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 1989; 320:1731-5.
11. Komanduri KV, Viswanathan MH, Wieder ED, Schmidt DK, Bredt BM, Jacobson MA, McCune JM. Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1. Nat Med 1998; 4:953-6.
12. Roman LI, Manzano L, De La Hera A, Abreu L, Rossi I, Alvarez-Mon M. Expanded CD4+CD45RO+ phenotype and defective proliferative response in T lymphocytes from patients with Crohn's disease. Gastroenterology 1996; 110:1008-19.
13. Giacomelli R, Passacantando A, Frieri G et al. Circulating soluble factor-inhibiting natural killer (NK) activity of fresh peripheral blood mononuclear cells (PBMC) from inflammatory bowel disease (IBD) patients. Clin Exp Imm 1999; 115:72-7.